M&T Bank Corp Abb Vie Inc. Call Options Transaction History

M&T Bank Corp

14 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 19, 2024	BUY	$163.84 - $199.33 $16,384 - $19,933	100 New	100 $19,000
Q2 2024 Jul 31, 2024	SELL	$154.79 - $180.76 $2,167 - $2,530	-14 Reduced 14.58%	82 $14,000
Q1 2024 May 07, 2024	BUY	$159.82 - $182.1 $2,876 - $3,277	18 Added 23.08%	96 $17,000
Q4 2023 Feb 06, 2024	BUY	$137.6 - $154.97 $2,064 - $2,324	15 Added 23.81%	78 $12,000
Q2 2023 Aug 09, 2023	SELL	$132.51 - $164.9 $6,625 - $8,245	-50 Reduced 44.25%	63 $8,000
Q1 2023 May 11, 2023	BUY	$144.61 - $166.54 $16,340 - $18,819	113 New	113 $18,000
Q1 2022 May 09, 2022	BUY	$131.98 - $163.75 $3,959 - $4,912	30 Added 76.92%	69 $200,000
Q4 2021 Feb 07, 2022	BUY	$107.43 - $135.93 $1,074 - $1,359	10 Added 34.48%	39 $33,000
Q3 2020 Nov 06, 2020	BUY	$85.91 - $100.83 $429 - $504	5 Added 20.83%	29 $0
Q4 2019 Feb 07, 2020	BUY	$72.13 - $90.25 $1,370 - $1,714	19 Added 380.0%	24 $5,000
Q1 2019 May 15, 2019	SELL	$77.14 - $90.79 $385 - $453	-5 Reduced 50.0%	5 $0
Q1 2018 May 04, 2018	SELL	$92.01 - $123.21 $184 - $246	-2 Reduced 16.67%	10 $23,000
Q4 2017 Feb 06, 2018	SELL	$89.56 - $98.21 $806 - $883	-9 Reduced 42.86%	12 $26,000
Q2 2017 Aug 11, 2017	BUY	N/A	21	21 $7,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

Stay updated on M&T Bank Corp with notifications on news.